Patents by Inventor Carl D. Murphy
Carl D. Murphy has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 5591809Abstract: The present invention provides novel one-step processes for preparing highly branched macromolecule polymers that have highly controlled molecular architectures. The process comprises the reaction of a branching monomer such as a substituted phenyl compound having the formula: ##STR1## wherein R.sub.1, R.sub.2, and R.sub.3 are defined herein, with a core monomer and an end-capping monomer, such as a phenolic ester, for a sufficient period of time and at a sufficient temperature to directly produce the highly branched polymer, in a single processing step.Type: GrantFiled: August 18, 1995Date of Patent: January 7, 1997Assignee: Hoechst Celanese CorporationInventors: Richard Vicari, Kathleen N. Juneau, Carl D. Murphy
-
Patent number: 5567795Abstract: The present invention provides novel one-step processes for preparing highly branched macromolecule polymers that have highly controlled molecular architectures. The process comprise the reaction of a branching monomer such as a substituted phenyl compound having the formula: ##STR1## wherein R.sub.1, R.sub.2, and R.sub.3 are defined herein, with a second monomer (an end-capping monomer) such as a phenolic ester for a sufficient period of time and at a sufficient temperature to directly produce the highly branched polymer, in a single processing step.Type: GrantFiled: August 18, 1995Date of Patent: October 22, 1996Assignee: Hoechst Celanese CorporationInventors: Richard Vicari, Kathleen N. Juneau, Carl D. Murphy
-
Patent number: 5399707Abstract: A process is provided whereby S(+)-ibuprofen or R(-)-ibuprofen L-lysinate salt is produced by selective precipitation from a mixture containing enantiomers of ibuprofen and L-lysine. The quantity of L-lysine is not more than about a molar equivalent of the quantity of one of the enantiomers in the ibuprofen enantiomeric mixture. Upon precipitation of one ibuprofen enantiomer from the mixture, the overall precipitate and reaction mixture can be held for a sufficient period of time at a second temperature to allow the first precipitate to redissolve into the reaction mixture and the other ibuprofen enantiomer to precipitate out of the mixture in the salt form. Optically active ibuprofen is racemized by being heated at 100.degree. C. to 300.degree. C. in the substantial absence of other materials.Type: GrantFiled: June 10, 1994Date of Patent: March 21, 1995Assignee: Hoechst Celanese CorporationInventors: Apurba Bhattacharya, John R. Fritch, Carl D. Murphy, Larry D. Zeagler, Carina A. McAdams
-
Patent number: 5380867Abstract: A process is provided whereby S(+)-ibuprofen or R(-)-ibuprofen L-lysinate salt is produced by selective precipitation from a mixture containing enantiomers of ibuprofen and L-lysine. The quantity of L-lysine is not more than about a molar equivalent of the quantity of one of the enantiomers in the ibuprofen enantiomeric mixture. Upon precipitation of one ibuprofen enantiomer from the mixture, the overall precipitate and reaction mixture can be held for a sufficient period of time at a second temperature to allow the first precipitate to redissolve into the reaction mixture and the other ibuprofen enantiomer to precipitate out of the mixture in the salt form. Optically active ibuprofen is racemized by being heated at 100.degree. C. to 300.degree. C. in the substantial absence of other materials.Type: GrantFiled: October 19, 1993Date of Patent: January 10, 1995Assignee: Hoechst Celanese CorporationInventors: Apurba Bhattacharya, John R. Fritch, Carl D. Murphy, Larry D. Zeagler, Carina A. McAdams
-
Patent number: 5332834Abstract: There is disclosed and claimed a process whereby S(+)-ibuprofen L-lysinate salt is produced by selective precipitation from a mixture containing enantiomers of ibuprofen and L-lysine. The quantity of L-lysine is not more than about a molar equivalent of the quantity of S(+)-ibuprofen in the ibuprofen enantiomeric mixture. The mother liquors after separating the above salt are enriched in R-ibuprofen which is racemized by a novel thermal racemization process and may then be recycled.Type: GrantFiled: December 2, 1992Date of Patent: July 26, 1994Assignee: Hoechst Celanese CorporationInventors: Apurba Bhattacharya, John R. Fritch, Carl D. Murphy, Larry D. Zeagler, Carina Araullo-McAdams
-
Patent number: 4894482Abstract: A process is provided for removing water from a mixture of hydrogen fluoride (HF), a carboxylic acid, e.g., acetic acid, and water by extractive distillation in the presence of a Lewis base as solvent, which does not azeotrope with water, forms bonds with the HF and carboxylic acid which can be broken by heat and has a boiling point at atmospheric pressure at least about 20.degree. C. above that of the carboxylic acid, e.g., N-methyl-2-pyrrolidone, and taking off an overhead vapor comprising a major proportion of the water in said mixture. The extractive distillation may be advantageously integrated in an overall process with the production of an aromatic ketone, e.g., 4-hydroxyacetophone, by the Friedel-Crafts acylation of an aromatic compound, e.g., phenol, with the carboxylic acid, using HF as catalyst, to produce a product mixture comprising the aromatic ketone, HF, carboxylic acid and water, and the removal of aromatic ketone from the product mixture by means of a solvent assisted distillation.Type: GrantFiled: December 6, 1988Date of Patent: January 16, 1990Assignee: Hoechst Celanese CorporationInventors: Daniel D. Lindley, Carl D. Murphy
-
Patent number: 4663485Abstract: A process is provided for the distillation of a composition containing 4-hydroxyacetophenone and hydrogen fluoride in the presence of an alkane assisting solvent having from 4 to 16 carbon atoms e.g. n-hexane or n-octane. The process is carried out to obtain an overhead vapor containing alkane solvent and most of the hydrogen fluoride in the feed, and a liquid residue containing most of the 4-hydroxyacetophenone in the feed. The overhead vapor is condensed to form two immiscible phases, one containing a preponderance of hydrogen fluoride and the other a preponderance of alkane solvent, with the latter phase being returned to the distillation as reflux. The liquid residue also separates into two immiscible layers, one containing most of the 4-hydroxyacetophenone in the feed which is recovered and the other a preponderance of alkane solvent.Type: GrantFiled: July 22, 1986Date of Patent: May 5, 1987Assignee: Celanese CorporationInventors: Carl D. Murphy, Donna L. Keene, Daniel D. Lindley
-
Patent number: 4358623Abstract: In catalytically oxidizing methanol in the vapor phase according to already-known processes for the production of formaldehyde, the hot formaldehyde-containing gaseous effluent of the catalytic converter is rapidly cooled by being passed through the tubes of a heat exchanger which are filled with balls composed of a solid which is substantially inert toward formaldehyde. As compared with a similar cooling system in which the tubes are empty or in which enhancement of heat transfer is attempted by using metal heat-transfer enhancement devices such as twisted metal ribbons, the present method affords reduced post-reaction decomposition of formaldehyde while at the same time allowing use of a relatively high temperature on the shell side of the heat exchanger whereby it becomes possible to raise steam at a pressure higher than that characteristic of the prior art.Type: GrantFiled: July 23, 1981Date of Patent: November 9, 1982Assignee: Celanese CorporationInventors: Carl D. Murphy, William P. McMillan